CardieX Limited (CDX.AX)

0.0540 +0.0010 (+1.89%) At close: 04:10PM AEST

CardieX Limited

55 Lime Street
Suite 301 Level 3
Sydney, NSW 2000
Australia
61 2 9874 8761
https://cardiex.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Niall Charles Edgar Cairns ACA, B.Ec, FAICD	Co-Founder & Executive Chairman	309.37k	N/A	1964
Mr. Craig R. Cooper BEC, L.L.B.	Co-Founder, Group CEO, MD & Executive Director	796.13k	N/A	1963
Dr. Ahmad Qasem Ph.D.	Chief Science & Research Officer	220.33k	N/A	1964
Dr. Steven Kesten	Chief Medical Officer	205.71k	N/A	1958
Dr. Mark Gorelick Ph.D.	Chief Product Officer	382.77k	N/A	1975
Ms. Catherine Liao	Chief Strategy Officer	366.45k	N/A	1979
Mr. Antony Sloan	Global Head of Marketing & Communications	N/A	N/A	N/A
Mr. Douglas T. Kurschinski	Executive VP & Head of Global Sales for AtCor Medical Division	342.61k	N/A	N/A
Ms. Louisa Ho	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

CardieX Limited designs, manufactures, and markets medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that measures arterial health by collecting digital vascular biomarkers using novel sensors. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables for home health, decentralized clinical trials, and remote patient monitoring. It sells its cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.

Corporate governance

CardieX Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.